Efficacy and safety of cardiac sympathetic denervation for refractory ventricular arrhythmias: Experience of a Colombian hospital

IF 0.3 Q4 SURGERY

Cirugia Cardiovascular Pub Date : 2024-03-01 DOI:10.1016/j.circv.2023.11.001

Nicolas Arredondo-Mora , Oscar Rincón-Barbosa , Carlos A. Rodríguez-Sabogal

{"title":"Efficacy and safety of cardiac sympathetic denervation for refractory ventricular arrhythmias: Experience of a Colombian hospital","authors":"Nicolas Arredondo-Mora , Oscar Rincón-Barbosa , Carlos A. Rodríguez-Sabogal","doi":"10.1016/j.circv.2023.11.001","DOIUrl":null,"url":null,"abstract":"<div><p>Left or bilateral cardiac sympathetic denervation is employed as a final option for treating pharmacologically refractory ventricular arrhythmias of various etiologies. In this study, we share our experience with bilateral cardiac denervation. A total of 6 patients (mean age 73.8 years±6.5 years, mean LVEF 37±8.3%), between 2021 and 2022, with sarcoidosis or ischemic heart disease underwent bilateral cardiac denervation due to electrical storm despite prior treatments. It was achieved complete resolution of ventricular arrhythmias in 100% of cases, with no recurrence of cardiac device shocks and no mortalities, neither cases of pneumothorax, Horner's syndrome, or other complications. Therefore, it was concluded that in this study, bilateral cardiac denervation was effective for treatment of refractory ventricular arrhythmias. Further larger studies are required to confirm these findings.</p></div>","PeriodicalId":42671,"journal":{"name":"Cirugia Cardiovascular","volume":"31 2","pages":"Pages 89-91"},"PeriodicalIF":0.3000,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1134009623001778/pdfft?md5=823323dab372f719cab2ecf8639b0429&pid=1-s2.0-S1134009623001778-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cirugia Cardiovascular","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1134009623001778","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"SURGERY","Score":null,"Total":0}

引用次数: 0

Abstract

Left or bilateral cardiac sympathetic denervation is employed as a final option for treating pharmacologically refractory ventricular arrhythmias of various etiologies. In this study, we share our experience with bilateral cardiac denervation. A total of 6 patients (mean age 73.8 years ± 6.5 years, mean LVEF 37 ± 8.3%), between 2021 and 2022, with sarcoidosis or ischemic heart disease underwent bilateral cardiac denervation due to electrical storm despite prior treatments. It was achieved complete resolution of ventricular arrhythmias in 100% of cases, with no recurrence of cardiac device shocks and no mortalities, neither cases of pneumothorax, Horner's syndrome, or other complications. Therefore, it was concluded that in this study, bilateral cardiac denervation was effective for treatment of refractory ventricular arrhythmias. Further larger studies are required to confirm these findings.

查看原文本刊更多论文

心脏交感神经去神经治疗难治性室性心律失常的有效性和安全性：哥伦比亚一家医院的经验

左侧或双侧心脏交感神经去神经化是治疗各种病因引起的药物难治性室性心律失常的最终选择。在本研究中，我们分享了双侧心脏交感神经去神经化的经验。在 2021 年至 2022 年期间，共有 6 名患有肉样瘤病或缺血性心脏病的患者（平均年龄为 73.8 岁 ± 6.5 岁，平均 LVEF 为 37 ± 8.3%）因电风暴而接受了双侧心脏去神经支配术。100%的病例室性心律失常得到完全缓解，无心脏装置电击复发，无死亡病例，也无气胸、霍纳综合征或其他并发症病例。因此，这项研究认为，双侧心脏去神经化治疗难治性室性心律失常是有效的。要证实这些研究结果，还需要进行更大规模的研究。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Cirugia Cardiovascular SURGERY-

CiteScore

0.50

自引率

66.70%

发文量

109

审稿时长

69 days